The Trump administration finalized new policies for some Medicare programs on Friday, but left out provisions that would have ...
FDA faces major shakeup as CBER chief Peter Marks exits, Trump admin implements cuts across HHS, and new tariff plan creates industry confusion. Sens. Cassidy and Sanders seek answers.
Relay Therapeutics does third round of layoffs in nine months, affecting about 70 employees
The Cambridge, MA-based biotech is letting go of about 70 employees, a spokesperson confirmed to Endpoints News on Friday ...
Shanghai's RiboX Therapeutics begins first-ever circular RNA clinical trial, targeting dry mouth in cancer patients. Company ...
Ousted FDA biologics and vaccine chief Peter Marks was asked to provide non-existent data on the risk from measles vaccines, ...
On the precipice of FDA approval, Novavax's Covid vaccine is now in limbo while a decision to approve or reject it is held up ...
Singapore VC firm Vickers Venture Partners files for $180M IPO for second SPAC, Vickers Vantage Corp. II, following 2022 ...
At least 2,000 of the 10,000 HHS employees let go this week will be reinstated because of “mistakes,” Robert F. Kennedy Jr.
NIH over grant disruptions amid Trump admin cuts, citing canceled grants on DEI/transgender/vaccine topics & mass layoffs of ...
GSK and Pfizer have settled a lawsuit alleging Pfizer’s RSV shot Abrysvo infringed GSK’s patents. A Pfizer ...
F-star Therapeutics becomes private, independent company after separating from invoX, plans to continue bispecific antibody ...
Eli Lilly licenses Sangamo's BBB-penetrating AAV capsid for CNS disease with $18M upfront; deal includes option for 4 more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback